OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)EuroSCORE IIFFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreReynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator

Clinical Evidence and Methodology

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Evaluation and grading of Mitral Stenosis (MS) severity during transthoracic or transesophageal echocardiography (TTE/TEE).
  • To monitor progression of native valve or bioprosthetic mitral stenosis.

Do Not Rely on if

Patient has severe Aortic Regurgitation, reduced LV compliance, or if assessed immediately following mitral valvuloplasty. These conditions alter the transmitral pressure gradient independent of the valve area.

CLINICAL INSIGHT

How it Works

Electrophysiological and Physical Basis

The Pressure Half-Time (PHT) is the time required for the peak transmitral pressure gradient to decline to one-half of its original value. In mitral stenosis, the time it takes for the pressure in the left atrium to equilize with the left ventricle is prolonged because the stenotic valve orifice restricts flow.

The 220 Constant

Empirically, a PHT of 220 ms has been found to correspond to a Mitral Valve Area (MVA) of 1.0 cm2. Thus, MVA = 220 / PHT.

Severity Grading (ASE)

  • Mild MS: MVA > 1.5 cm2 (PHT < 150 ms)
  • Moderate MS: MVA 1.0–1.5 cm2 (PHT 150–220 ms)
  • Severe MS: MVA < 1.0 cm2 (PHT > 220 ms)
CLINICAL INSIGHT

Practical Pearls

Confounding Factors

If left ventricular compliance is reduced (e.g., in elderly patients with LVH/HTN), the PHT will be shortened, falsely underestimating the severity of MS. Conversely, if LA compliance is increased, the PHT will be lengthened.

Gold Standard

Planimetry of the mitral valve in the short-axis view remains the anatomical gold standard for MVA, but can be technically difficult and requires excellent image quality.

CLINICAL INSIGHT

Evidence Base

Refining the Measurement

Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound.

Hatle L, Angelsen B, Tromsdal A.Circulation.1979

Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.

Baumgartner H, Hung J, Bermejo J, et al.J Am Soc Echocardiogr.2009
CLINICAL INSIGHT

Next Steps

Complementary Calculators

MVA (Pressure Half-Time)

MVA (Pressure Half-Time): Estimates Mitral Valve Area from the deceleration of mitral inflow. Standard method for grading Mitral Stenosis.

No clinical reference data available.